Auricularia and Gut Microbiome Modulation

Wood Ear Gut Health

200 mg/kg/day

The optimal dose of Auricularia polysaccharides for gut microbiota improvement in diabetic mice, producing the strongest shift in bacterial composition.

Liu et al., Molecules, 2022

Lactobacillus Increase

consistent across 3 independent studies

Firmicutes/Bacteroidetes

ratio decreased toward healthy baseline

0 Human Trials

all evidence from mouse models

Liu et al., Molecules, 2022

View as image ↗

Auricularia auricula, commonly known as wood ear or black fungus, is one of the most widely consumed edible mushrooms in Asia. Its polysaccharides resist digestion in the upper gastrointestinal tract and reach the colon intact, where gut bacteria ferment them. This fermentation process selectively feeds certain bacterial populations while starving others, producing measurable shifts in the gut microbiome. Seven studies published between 1998 and 2024 have characterized these shifts, with three using 16S rRNA sequencing to map the full bacterial landscape. The findings converge on a consistent pattern: Auricularia polysaccharides increase beneficial genera like Lactobacillus and Bacteroides while suppressing potentially harmful species. All evidence comes from rodent models.

For related topics, see wood ear for gut health: high fiber prebiotic effects and wood ear dietary fiber: one of the highest among mushrooms.

What Makes Auricularia Polysaccharides Prebiotic

Auricularia auricula polysaccharides (AAPs) are large, complex carbohydrate molecules that human and rodent digestive enzymes cannot break down. This indigestibility is the key to their prebiotic function: they pass through the stomach and small intestine unchanged and arrive in the colon, where anaerobic bacteria ferment them into short-chain fatty acids (SCFAs) and other metabolites.^[1]

The structural characteristics of AAPs matter. Shi et al. (2024) determined that acid hydrolysates of Auricularia polysaccharides consist mainly of mannose, xylose, glucuronic acid, and glucose, with a weight-averaged molecular weight of 6.38 x 10^4 Daltons.^[2] The glycosidic bonds include alpha-Glc(1-4), beta-Glc(1-3), and beta-Man(1-4) linkages. Shu et al. (2023) found that O-acetyl groups on the polysaccharide backbone are functionally relevant: when these groups were chemically removed (deacetylated AAPs), the anti-inflammatory effects decreased.^[3] This means the specific chemical decoration of the polysaccharide, not just the sugar backbone, affects biological activity.

The earliest evidence of Auricularia's metabolic effects came from Yuan et al. (1998), who showed that water-soluble polysaccharide from Auricularia fruiting bodies at 30 g/kg of diet lowered plasma glucose, insulin, and urinary glucose in genetically diabetic KK-Ay mice.^[4] The mechanism was unknown at the time, but modern gut microbiome research has since offered a plausible explanation.

How Auricularia Reshapes Gut Bacteria

Three studies have used 16S rRNA gene sequencing to map the comprehensive effects of AAP on gut bacterial communities. The results are remarkably consistent.

Xu et al. (2021) administered AAPs at 50 and 100 mg/kg to high-fat diet and streptozotocin-induced diabetic C57BL/6J mice.^[1] Both doses elevated gut microbiota diversity and optimized microbial composition, characterized by:

• Increased Lactobacillus and Bacteroides abundance
• Decreased Clostridium and Allobaculum abundance
• Improved amino acid and glycolipid metabolism pathways

The microbial shifts correlated with reduced inflammation, lower insulin resistance, and decreased liver injury through AKT and AMPK signaling pathway activation.

Liu et al. (2022) tested AAP at 100, 200, and 400 mg/kg/day in a similar HFD/STZ diabetic mouse model.^[5] The 200 mg/kg dose showed the strongest effects. Key microbiome changes included:

• Decreased Firmicutes abundance
• Increased Bacteroidetes abundance (the Firmicutes-to-Bacteroidetes ratio is a widely studied marker of gut health, with elevated ratios linked to obesity and metabolic disease)
• Increased Faecalibaculum, Dubosiella, and Alloprevotella (all associated with healthy gut function)
• Increased Lachnospiraceae family members (SCFA producers)
• Decreased Desulfovibrio (a sulfate-reducing bacterium linked to gut inflammation), Enterorhabdus, and Helicobacter

The study also confirmed AAP enhanced superoxide dismutase, catalase, and glutathione peroxidase activities while reducing malondialdehyde, connecting gut microbiome changes to systemic antioxidant improvements.

Shu et al. (2023) examined AAP effects in a NAFLD model rather than diabetes, providing cross-disease validation of the microbiome findings.^[3] In mice with high-fat, high-cholesterol diet plus CCl4-induced NAFLD, both AAPs and deacetylated AAPs:

• Enriched Odoribacter, Lactobacillus, Dorea, and Bifidobacterium
• Maintained intestinal barrier function
• Relieved liver injury, inflammation, and fibrosis

The Lactobacillus and Bifidobacterium enrichment appeared across all three studies despite different disease models, different doses, and different research groups. This consistency strengthens the finding, though all three used C57BL/6J mice, which limits generalizability.

The Gut-Metabolism Connection

The gut microbiome changes driven by AAP do not exist in isolation. They cascade into measurable metabolic effects through at least two mechanisms.

Bile Acid Metabolism

Shu et al. (2023) traced a specific mechanistic chain from gut bacteria to liver protection.^[3] The enrichment of Lactobacillus and Bifidobacterium altered the bile acid (BA) profile, increasing deoxycholic acid (DCA). DCA and other unconjugated bile acids activated the Farnesoid X receptor (FXR), which regulates bile acid metabolism and alleviated cholestasis. This gut-to-liver signaling pathway explains how changes in colonic bacteria can protect a distant organ.

This FXR activation pathway is the same mechanism targeted by obeticholic acid, a pharmaceutical drug in clinical trials for NASH. The fact that Auricularia polysaccharides engage this pathway through microbiome modulation rather than direct receptor binding suggests a fundamentally different pharmacological approach.

Systemic Metabolomics

Liu et al. (2021) conducted metabolomic profiling after AAP intervention in diabetic mice, identifying 45 differential metabolites as biomarkers.^[6] AAP at 200 mg/kg/day affected metabolism of amino acids, unsaturated fatty acids, bile acids, and glycerophospholipids. While this study did not directly sequence the microbiome, the metabolite changes (particularly in bile acids and amino acids) are consistent with gut bacteria-mediated effects. The 45 biomarkers provide a detailed molecular fingerprint of AAP's systemic impact.

Lu et al. (2018) showed that simulated gastrointestinal hydrolysates of Auricularia polysaccharides, composed of arabinose, xylose, mannose, glucose, galactose, and glucosamine, retained hypoglycemic activity in STZ-induced diabetic rats.^[7] At 0.15 g/kg for 7 weeks, these hydrolysates increased hepatic glycogen and pancreatic insulin while decreasing triglycerides and LDL cholesterol. The fact that digestion-simulated fragments retain activity suggests the polysaccharide breakdown products, not just intact molecules, contribute to gut-mediated effects.

The Structural Factor: Why O-Acetyl Groups Matter

Shu et al. (2023) made an observation with practical implications: removing O-acetyl groups from AAP through alkaline treatment reduced the anti-inflammatory benefit.^[3] Both acetylated and deacetylated forms modulated the gut microbiota and maintained intestinal barrier function, but the native (acetylated) form provided stronger anti-inflammatory effects.

This has implications for how Auricularia is processed and consumed. Aggressive alkaline processing, high-heat treatment, or certain extraction methods could strip these O-acetyl groups and diminish the prebiotic benefit. Traditional food preparation methods, which typically involve gentle rehydration and brief cooking, may better preserve this structural feature. For more on dietary fiber content, see wood ear dietary fiber: one of the highest among mushrooms. For traditional digestive applications, see wood ear and constipation relief: traditional use.

Dose-Response and Timing Patterns

The three microbiome studies tested different dose ranges, providing some insight into dose-response relationships. Xu et al. (2021) used 50 and 100 mg/kg, both effective.^[1] Liu et al. (2022) compared 100, 200, and 400 mg/kg and found 200 mg/kg produced the best improvement, suggesting a non-linear dose-response where more is not necessarily better.^[5] Shi et al. (2024) similarly found 100 mg/kg outperformed higher doses for glucose metabolism endpoints.^[2]

Intervention duration ranged from 5 weeks (Liu et al., 2022) to 8 weeks (Shi et al., 2024). All studies reported measurable microbiome shifts within these timeframes, but none included a washout period to determine whether the changes persist after supplementation ends. In pharmaceutical prebiotic research, this rebound question is critical: if the microbiome reverts to its pre-treatment state within days of stopping the prebiotic, the practical value changes substantially.

The timing pattern also raises questions about which changes come first. Does AAP directly feed beneficial bacteria, which then produce metabolites that improve metabolic markers? Or does AAP independently affect both the microbiome and metabolism through separate pathways? The Shu et al. (2023) bile acid data suggest at least one pathway runs through the microbiome, but parallel direct effects cannot be excluded.

For context on how Auricularia polysaccharides affect blood sugar regulation specifically, see Auricularia and alpha-glucosidase inhibition: slowing sugar absorption. For broader transit effects, see wood ear and gut transit time: soluble fiber effects on digestion.

What the Evidence Does Not Show

No human microbiome data exist. All seven studies used rodent models. The human gut microbiome differs from the mouse microbiome in composition, diversity, and response to dietary interventions. The consistent Lactobacillus and Bacteroidetes increases in mice may or may not translate to humans.

The optimal dose for humans is unknown. Mouse studies used 50 to 400 mg/kg/day of purified polysaccharides. Translating this to a human eating whole wood ear mushrooms involves unknown variables: polysaccharide concentration in food-grade mushroom, extraction efficiency during digestion, and inter-individual variation in gut bacteria.

Long-term effects are unstudied. The longest intervention period was 8 weeks (Shi et al., 2024). Whether the microbiome shifts persist after stopping AAP supplementation, or whether tolerance develops over months of use, remains unknown.

Causation versus correlation. While three studies show microbiome changes alongside metabolic improvements, only Shu et al. (2023) traced a specific mechanistic chain (bacteria to bile acids to FXR to liver protection). For the other studies, the microbiome shift and the metabolic improvement could both be downstream effects of something else.

SCFA data are limited. Web-based reviews describe AAP as promoting SCFA production, but the studies reviewed here measured bacterial composition and metabolic endpoints, not fecal SCFA concentrations directly. The SCFA connection, while biologically plausible, needs direct measurement in Auricularia-specific studies.

Strain-level resolution is missing. The 16S rRNA sequencing used in these studies identifies bacteria at the genus level. Different species and strains within Lactobacillus or Bacteroides can have vastly different metabolic functions. Without strain-level shotgun metagenomic data, the functional implications of the observed shifts remain somewhat speculative.

Inter-individual variation is unaddressed. Even within inbred mouse strains, gut microbiome composition varies between individuals. Human gut microbiomes are far more variable. A polysaccharide that robustly shifts C57BL/6J mouse microbiomes may have inconsistent effects across humans with different baseline bacterial compositions, diets, and genetic backgrounds.

The Bottom Line

Auricularia auricula polysaccharides consistently reshape gut bacterial communities in mouse models, increasing beneficial genera (Lactobacillus, Bacteroides, Bifidobacterium) while suppressing harmful ones (Clostridium, Desulfovibrio, Helicobacter). This pattern holds across diabetes and NAFLD disease models. The microbiome changes connect to measurable metabolic effects through bile acid signaling and systemic metabolite shifts. The structural features of the polysaccharide, including O-acetyl groups, influence biological potency. All evidence is preclinical; human microbiome studies have not been conducted.

Frequently Asked Questions

Is wood ear mushroom good for gut health?

Wood ear mushroom (Auricularia auricula) contains polysaccharides that act as prebiotics, feeding beneficial gut bacteria. In mouse studies, these polysaccharides increased Lactobacillus, Bacteroides, and Bifidobacterium while decreasing harmful species like Desulfovibrio and Helicobacter (Xu et al., 2021; Liu et al., 2022; Shu et al., 2023). Wood ear also has one of the highest dietary fiber contents among edible mushrooms. No human gut microbiome studies have been conducted with Auricularia polysaccharides specifically.

Does wood ear mushroom have prebiotic effects?

Auricularia polysaccharides resist digestion and reach the colon intact, where gut bacteria ferment them. Three independent mouse studies using 16S rRNA sequencing confirmed that AAP selectively promotes beneficial bacteria growth (Xu et al., 2021; Liu et al., 2022; Shu et al., 2023). The enrichment of SCFA-producing bacteria like Lachnospiraceae members supports the prebiotic classification. Processing method matters: removing O-acetyl groups from the polysaccharides reduced their anti-inflammatory benefit (Shu et al., 2023).

How does Auricularia affect the gut microbiome?

Auricularia polysaccharides shift the gut bacterial balance by decreasing the Firmicutes-to-Bacteroidetes ratio, a marker associated with improved metabolic health. Specific changes include increased Lactobacillus, Bacteroides, Bifidobacterium, and Faecalibaculum, alongside decreased Clostridium, Desulfovibrio, and Helicobacter (Liu et al., 2022). These changes correlate with improved antioxidant enzyme activity and reduced inflammation in diabetic mouse models.

Can wood ear mushroom help with fatty liver through gut bacteria?

One study directly tested this connection. Shu et al. (2023) showed Auricularia polysaccharides alleviated NAFLD in mice by modulating gut microbiota, which changed bile acid profiles. The enrichment of Lactobacillus and Bifidobacterium increased deoxycholic acid production, activating the Farnesoid X receptor and protecting against liver inflammation and fibrosis. This is a single preclinical study; the gut-liver pathway has not been confirmed in humans with fatty liver disease.

How much Auricularia is needed for gut health benefits?

In mouse studies, 200 mg/kg/day of purified Auricularia polysaccharides showed the strongest gut microbiome improvements (Liu et al., 2022). Lower doses of 50 and 100 mg/kg also produced measurable effects (Xu et al., 2021). These are doses of isolated polysaccharides, not whole mushroom. The equivalent amount from food-grade wood ear mushroom is unknown because polysaccharide concentration varies by source and preparation. No human dosing studies have been conducted.

Is Auricularia better than other mushrooms for gut health?

Direct comparison data are limited. Auricularia auricula has among the highest dietary fiber content of any edible mushroom, which supports its prebiotic potential. However, one in vitro study noted that Auricularia auricula-judae stimulated bifidobacteria and lactobacilli growth less than some other mushroom species. The three in vivo studies reviewed here show consistent microbiome modulation, but equivalent 16S sequencing studies with other mushroom polysaccharides would be needed for a fair comparison.

Sources & References

1. 1RTHM-00728·Xu, Nuo et al. (2021). “Auricularia auricula-judae (Bull.) polysaccharides improve type 2 diabetes in HFD/STZ-induced mice by regulating the AKT/AMPK signaling pathways and the gut microbiota..” Journal of food science.Study breakdown →PubMed →↩
2. 2RTHM-00909·Shi, Qianwen et al. (2024). “Effects of Auricularia auricula-judae (Bull.) Quél. polysaccharide acid hydrolysate on glucose metabolism in diabetic mice under oxidative stress..” Phytomedicine : international journal of phytotherapy and phytopharmacology.Study breakdown →PubMed →↩
3. 3RTHM-00852·Shu, Yifan et al. (2023). “The polysaccharides from Auricularia auricula alleviate non-alcoholic fatty liver disease via modulating gut microbiota and bile acids metabolism..” International journal of biological macromolecules.Study breakdown →PubMed →↩
4. 4RTHM-00028·Yuan, Z et al. (1998). “Hypoglycemic effect of water-soluble polysaccharide from Auricularia auricula-judae Quel. on genetically diabetic KK-Ay mice..” Bioscience.Study breakdown →PubMed →↩
5. 5RTHM-00780·Liu, Nannan et al. (2022). “Effects of Auricularia auricula Polysaccharides on Gut Microbiota Composition in Type 2 Diabetic Mice..” Molecules (Basel.Study breakdown →PubMed →↩
6. 6RTHM-00704·Liu, Nannan et al. (2021). “Hypoglycemic effects of Auricularia auricula polysaccharides on high fat diet and streptozotocin-induced diabetic mice using metabolomics analysis..” Food & function.Study breakdown →PubMed →↩
7. 7RTHM-00522·Lu, Aoxue et al. (2018). “Preparation of the Auricularia auricular polysaccharides simulated hydrolysates and their hypoglycaemic effect..” International journal of biological macromolecules.Study breakdown →PubMed →↩